HEALTHXCHANGE PHARMACY UK LIMITED
Get an alert when HEALTHXCHANGE PHARMACY UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-07 (in 9mo)
Last made up 2026-01-24
Watchouts
None on the register
Cash
£11M
-2.2% vs 2023
Net assets
£5M
+161.2% vs 2023
Employees
128
+26.7% vs 2023
Profit before tax
£4M
+105.7% vs 2023
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £34,456,621 | £44,174,032 | |
| Operating profit | £1,774,620 | £3,786,906 | |
| Profit before tax | £1,777,614 | £3,657,437 | |
| Net profit | £1,472,515 | £2,823,078 | |
| Cash | £11,309,909 | £11,066,235 | |
| Total assets less current liabilities | £2,010,056 | £4,772,049 | |
| Net assets | £1,729,168 | £4,517,328 | |
| Equity | £1,729,168 | £4,517,328 | |
| Average employees | 101 | 128 | |
| Wages | £4,448,498 | £6,726,844 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 5.2% | 8.6% | |
| Net margin | 4.3% | 6.4% | |
| Return on capital employed | 88.3% | 79.4% | |
| Current ratio | 1.03x | 1.16x | |
| Interest cover | 39.95x | 25.46x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Buzzacott Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's or the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- HEALTHXCHANGE PHARMACY UK LIMITED · parent
- Healthxchange Ireland Limited 1%
- Clever Beauty Ireland Limited 1%
- Clever Aesthetic Tech Limited 1%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MCS FORMATIONS LIMITED | Corporate Secretary | 2006-04-25 | — | — |
| CURRAN, Jack Xavier | Director | 2015-09-01 | Jun 1994 | British |
| GLENISTER, Scott Brian | Director | 2024-09-19 | Aug 1975 | British |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PLUMMER, Guy Willson | Secretary | 2005-11-04 | 2006-04-25 |
| SIMPSON, Douglas John | Secretary | — | 2005-11-04 |
| BERG, Sarah Caroline | Director | — | 2005-11-04 |
| HILL, Karen | Director | 2005-11-04 | 2023-05-31 |
| SIMPSON, Douglas John | Director | — | 2005-11-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr John Gerald Curran | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Active |
| Mrs Christine Mary Curran | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Active |
| Dr Robert George Hanna | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 124 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-01 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-08-07 | AA | accounts | Accounts with accounts type group | |
| 2025-04-28 | CH01 | officers | Change person director company with change date | |
| 2025-04-28 | CH01 | officers | Change person director company with change date | |
| 2025-02-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-14 | AA | accounts | Accounts with made up date | |
| 2024-09-19 | CH01 | officers | Change person director company with change date | |
| 2024-09-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-19 | AA01 | accounts | Change account reference date company previous extended | |
| 2024-01-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-05 | AA | accounts | Accounts with accounts type group | |
| 2023-06-12 | TM01 | officers | Termination director company with name termination date | |
| 2023-02-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-13 | AA | accounts | Accounts with accounts type total exemption full | |
| 2022-05-19 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-02-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-16 | AA | accounts | Accounts with accounts type total exemption full | |
| 2021-02-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-01-22 | AA | accounts | Accounts with accounts type total exemption full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+28.2%
£34,456,621 £44,174,032
-
Cash
-2.2%
£11,309,909 £11,066,235
-
Net assets
+161.2%
£1,729,168 £4,517,328
-
Employees
+26.7%
101 128
-
Operating profit
+113.4%
£1,774,620 £3,786,906
-
Profit before tax
+105.7%
£1,777,614 £3,657,437
-
Wages
+51.2%
£4,448,498 £6,726,844
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers